Novo Nordisk A/S ( NOVO-B.CO) - Stock Earnings
NOVO-B.CO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026 AfterMarket | — / — | — | — / — | — |
NOVO-B.CO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 20.0 billion DKK | 75.0 billion DKK |
| 2025Q4 | 26.9 billion DKK | 79.1 billion DKK |
| 2026Q1 | 48.6 billion DKK | 96.8 billion DKK |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NOVO-B.CO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 83.7 billion DKK | 232.3 billion DKK |
| 2024 | 101.0 billion DKK | 290.4 billion DKK |
| 2025 | 102.4 billion DKK | 309.1 billion DKK |
| 2026 Est. | — | — |
NOVO-B.CO
Price: DKK287.25
Dividend Yield: 3.90%
Forward Dividend Yield: 5.54%
Payout Ratio: 34.79%
Dividend Per Share: 15.90 DKK
Earnings Per Share: 27.42 DKK
P/E Ratio: 11.01
Exchange: CPH
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Volume: 2.2 million
Market Capitalization: 1.3 trillion
Average Dividend Frequency: 2
Years Paying Dividends: 27
DGR3: 8.84%
DGR5: 9.95%
DGR10: 13.03%
DGR20: 11.63%